BCR-ABL-IN-1 is an inhibitor of BCR-ABL tyrosine kinase, with a pIC 50 of 6.46, and may be used in the research of chronic myelogenous leukemia.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Bcr-Abl
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.